Status:
RECRUITING
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Hematopoietic Cell Transplantation Recipient
Leukemia
Eligibility:
All Genders
Brief Summary
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep tr...
Detailed Description
PRIMARY OBJECTIVES: I. To develop a mechanism for tracking and retaining patients enrolled on Children's Oncology Group (COG) protocols. II. To maintain regular, lifetime contact with patients in or...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The patient must reside in the U.S. on the date of enrollment to ALTE05N1
- All patients and/or their parents or legal guardians must sign a written informed consent
- All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met
Exclusion
Key Trial Info
Start Date :
July 17 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00736749
Start Date
July 17 2008
Last Update
July 23 2025
Active Locations (164)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Alabama
Birmingham, Alabama, United States, 35233
2
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States, 35233
3
USA Health Strada Patient Care Center
Mobile, Alabama, United States, 36604
4
Phoenix Childrens Hospital
Phoenix, Arizona, United States, 85016